Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 11, 2010 - Issue 7
Submit an article Journal homepage
480
Views
16
CrossRef citations to date
0
Altmetric
Drug Evaluations

Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature

Michele Mancini Eli Lilly Italia SpA, Medical Deparment, via Gramsci 731, 50019 Sesto Fiorentino (Florence), Italy +39 055 4257534; +39 055 4257348; [email protected]
, MD,
Giampaolo Perna San Benedetto Hospital, Department of Clinical Neurosciences, via Roma 16, 22032 Albese con Cassano (Como), Italy
, MD PhD,
Andrea Rossi Eli Lilly Italia SpA, Medical Deparment, via Gramsci 731, 50019 Sesto Fiorentino (Florence), Italy +39 055 4257534; +39 055 4257348; [email protected]
, PharmD &
Antonino Petralia Catania University, Psychiatric Department, via Santa Sofia 78, 95126 Catania, Italy
, MD PhD
Pages 1167-1181 | Published online: 19 Apr 2010

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Alessandro Parisi, Maria Vittoria Pensieri, Alessio Cortellini, Carla D’Orazio, Corrado Ficorella, Lucilla Verna & Giampiero Porzio. (2020) Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series. Journal of Addictive Diseases 38:2, pages 229-234.
Read now
Giampaolo Perna, Giuseppe Guerriero & Daniela Caldirola. (2011) Emerging drugs for panic disorder. Expert Opinion on Emerging Drugs 16:4, pages 631-645.
Read now
Istvan Bitter, Dora Filipovits & Pal Czobor. (2011) Adverse reactions to duloxetine in depression. Expert Opinion on Drug Safety 10:6, pages 839-850.
Read now
Jennifer A Reinhold, Laura A Mandos, Karl Rickels & Falk W Lohoff. (2011) Pharmacological treatment of generalized anxiety disorder. Expert Opinion on Pharmacotherapy 12:16, pages 2457-2467.
Read now

Articles from other publishers (12)

Faiza Siddiqui, Marija Barbateskovic, Sophie Juul, Kiran Kumar Katakam, Klaus Munkholm, Christian Gluud & Janus Christian Jakobsen. (2021) Duloxetine versus ‘active’ placebo, placebo or no intervention for major depressive disorder; a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Systematic Reviews 10:1.
Crossref
Declan T. Barry, Mark Beitel, Christopher J. Cutter, David A. Fiellin, Lynn M. Madden, Nathan Lipkind, Pooja Bollampally, Christopher Liong & Richard S. Schottenfeld. (2021) Psychiatric comorbidity and order of condition onset among patients seeking treatment for chronic pain and opioid use disorder. Drug and Alcohol Dependence 221, pages 108608.
Crossref
Bing Hu. 2021. The Neuroscience of Depression. The Neuroscience of Depression 357 368 .
Rajiv Kumar, Amita Sarwal, Lalita Dahiya, Dikshi Gupta & V. R. Sinha. (2019) Experimental investigations, cytotoxicity and cellular uptake outcomes of physically modified duloxetine HCl inclusion complexes. Polymer Bulletin 76:11, pages 5865-5887.
Crossref
Se-Il GoHaa-Na SongSo-Jin LeeEduardo BrueraJung Hun Kang. (2018) Craving Behavior from Opioid Addiction Controlled with Olanzapine in an Advanced Cancer Patient: A Case Report. Journal of Palliative Medicine 21:9, pages 1367-1370.
Crossref
Sarah Hasan Siddiqui, Nadeem Ahmed Memon & Ravi Shanker. (2018) Drug-induced movement disorder and confusion associated with duloxetine. BMJ Case Reports, pages bcr-2016-216746.
Crossref
A. Ojagbemi, M. Owolabi, R. Akinyemi, O. Arulogun, J. Akinyemi, O. Akpa, F. S. Sarfo, E. Uvere, R. Saulson, S. Hurst & B. Ovbiagele. (2017) Prevalence and predictors of anxiety in an African sample of recent stroke survivors. Acta Neurologica Scandinavica 136:6, pages 617-623.
Crossref
Akin Ojagbemi, Mayowa Owolabi, Joshua Akinyemi & Bruce Ovbiagele. (2017) Proposing a new stroke-specific screening tool for depression: Examination of construct validity and reliability. eNeurologicalSci 9, pages 14-18.
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 111 143 .
Mathieu Bilodeau, Tarek Simon, Miriam H. Beauchamp, Paul Lespérance, Simon Dubreucq, Jean-Pierre Dorée & Smadar Valérie Tourjman. (2012) Duloxetine in Adults With ADHD. Journal of Attention Disorders 18:2, pages 169-175.
Crossref
Joseph V. PergolizziJrJr, Robert B. Raffa, Robert TaylorJrJr, Gabriel Rodriguez, Srinivas Nalamachu & Paul Langley. (2012) A Review of Duloxetine 60 mg Once‐Daily Dosing for the Management of Diabetic Peripheral Neuropathic Pain, Fibromyalgia, and Chronic Musculoskeletal Pain Due to Chronic Osteoarthritis Pain and Low Back Pain. Pain Practice 13:3, pages 239-252.
Crossref
Riccardo Torta, Paolo Leombruni, Roberto Borio & Lorys Castelli. (2011) Duloxetine for the treatment of mood disorder in cancer patients: a 12-week case-control clinical trial. Human Psychopharmacology: Clinical and Experimental 26:4-5, pages 291-299.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.